Company Filing History:
2 out of 38 
1 out of 1 
1 out of 4 Years Active: 2021-2024
Title: Estefanía Cerro Herreros: Innovator in Oligonucleotide Research
Introduction
Estefanía Cerro Herreros is a prominent inventor based in Valencia, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. With a total of two patents to his name, his work focuses on innovative solutions for treating genetic disorders.
Latest Patents
His latest patents include "Oligonucleotides conjugated to oleic acid and uses thereof" and "Modulation of microRNAs against myotonic dystrophy type 1 and antagonists of microRNAs therefor." The first patent provides oligonucleotide molecules that act as antagonists of specific microRNAs, which can increase the levels of proteins MBNL1 and MBNL2. This invention has potential applications in treating and preventing myotonic dystrophy. The second patent emphasizes the use of inhibitors for microRNAs that repress MBNL1 and MBNL2 genes, aiming to alleviate symptoms of myotonic dystrophy type 1 by enhancing the expression of these proteins.
Career Highlights
Estefanía has worked with notable institutions such as Universitat De Valencia and Arthex Biotech S.L. His research has been pivotal in advancing therapeutic strategies for genetic conditions, showcasing his commitment to improving patient outcomes through innovative science.
Collaborations
He has collaborated with esteemed colleagues, including Rubén Artero Allepuz and Nerea Moreno Cervera. These partnerships have further enriched his research endeavors and contributed to the success of his inventions.
Conclusion
Estefanía Cerro Herreros stands out as a key figure in the field of oligonucleotide research, with his patents paving the way for new treatments for myotonic dystrophy. His work exemplifies the impact of innovation in biotechnology and its potential to transform lives.